Advanced search
Add to list

16 alpha-[(18)F]-fluoro-17 beta-estradiol positron emission tomography (FES-PET) to detect ER positive tumor lesions in breast cancer patients with a diagnostic dilemma

Author
Organization

Citation

Please use this url to cite or link to this publication:

MLA
Glaudemans, AWJM, EFJ de Vries, M van Kruchten, et al. “16 alpha-[(18)F]-fluoro-17 Beta-estradiol Positron Emission Tomography (FES-PET) to Detect ER Positive Tumor Lesions in Breast Cancer Patients with a Diagnostic Dilemma.” European Journal of Nuclear Medicine and Molecular Imaging. Vol. 37. 2010. S246–S246. Print.
APA
Glaudemans, AWJM, de Vries, E., van Kruchten, M., de Vries, E., Slart, R., Dierckx, R., & Hospers, G. (2010). 16 alpha-[(18)F]-fluoro-17 beta-estradiol positron emission tomography (FES-PET) to detect ER positive tumor lesions in breast cancer patients with a diagnostic dilemma. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (Vol. 37, pp. S246–S246). Presented at the 23rd Annual Congress of the European-Association-of-Nuclear-Medicine (EANM - 2010).
Chicago author-date
Glaudemans, AWJM, EFJ de Vries, M van Kruchten, EGE de Vries, RHJA Slart, Rudi Dierckx, and GAP Hospers. 2010. “16 alpha-[(18)F]-fluoro-17 Beta-estradiol Positron Emission Tomography (FES-PET) to Detect ER Positive Tumor Lesions in Breast Cancer Patients with a Diagnostic Dilemma.” In European Journal of Nuclear Medicine and Molecular Imaging, 37:S246–S246.
Chicago author-date (all authors)
Glaudemans, AWJM, EFJ de Vries, M van Kruchten, EGE de Vries, RHJA Slart, Rudi Dierckx, and GAP Hospers. 2010. “16 alpha-[(18)F]-fluoro-17 Beta-estradiol Positron Emission Tomography (FES-PET) to Detect ER Positive Tumor Lesions in Breast Cancer Patients with a Diagnostic Dilemma.” In European Journal of Nuclear Medicine and Molecular Imaging, 37:S246–S246.
Vancouver
1.
Glaudemans A, de Vries E, van Kruchten M, de Vries E, Slart R, Dierckx R, et al. 16 alpha-[(18)F]-fluoro-17 beta-estradiol positron emission tomography (FES-PET) to detect ER positive tumor lesions in breast cancer patients with a diagnostic dilemma. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2010. p. S246–S246.
IEEE
[1]
A. Glaudemans et al., “16 alpha-[(18)F]-fluoro-17 beta-estradiol positron emission tomography (FES-PET) to detect ER positive tumor lesions in breast cancer patients with a diagnostic dilemma,” in EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, Vienna, Austria, 2010, vol. 37, no. Suppl. 2, pp. S246–S246.
@inproceedings{1931118,
  author       = {Glaudemans, AWJM and de Vries, EFJ and van Kruchten, M and de Vries, EGE and Slart, RHJA and Dierckx, Rudi and Hospers, GAP},
  booktitle    = {EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING},
  issn         = {1619-7070},
  language     = {eng},
  location     = {Vienna, Austria},
  number       = {Suppl. 2},
  pages        = {S246--S246},
  title        = {16 alpha-[(18)F]-fluoro-17 beta-estradiol positron emission tomography (FES-PET) to detect ER positive tumor lesions in breast cancer patients with a diagnostic dilemma},
  volume       = {37},
  year         = {2010},
}

Web of Science
Times cited: